Advertise

Subscribe

Log in | Register

News
- Agencies
- Data/Analytics
- Campaigns
- Commercial
- Corporate
- Legal/Regulatory
- Media
- Payers
- Pipeline
- Technology
DTC Report 2018: Will more supersized campaigns follow Opdivo's and Keytruda's massive strikes?

Following massive strikes by Opdivo and Keytruda, will more supersized campaigns follow?
Dr. Reddy's Laboratories CEO of developed markets Alok Sonig makes Wall Street listen

Alok Sonig, chief executive officer of developed markets at Dr. Reddy's Laboratories, articulates the benefits of generics.
DTC ads 2017: The good, the bad, and the ugly

We considered pharma and healthcare ads that, per iSpotTV, started airing no earlier than January 2017.
Series
Profiles in Creativity

This six-part series, produced by the MM&M Content Lab in partnership with Klick Health, tells personal stories of people using creativity to solve problems in healthcare.
Events
Videos
Resources
Careers
Magazine
- Latest Issue
- Issue Archive

Hemophilia A

Five things for pharma marketers to know: Thursday, May 11, 2017

Five things for pharma marketers to know: Thursday, May 11, 2017

By Virginia Lau May 11, 2017

FDA approves Merck/Lilly combo for lung cancer; new PhRMA requirements result in expulsion of 22 members; Pfizer to pay Sangamo $7 million for gene therapy programs

Roche gears up to enter loaded hemophilia A drug market

Roche gears up to enter loaded hemophilia A drug market

By Rebecca Mayer Knutsen February 16, 2017

A loaded hemophilia A drug market is an indication patients in and around it are well-served, but that hasn't stopped contenders such as Roche's emicizumab.